How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
This study aimed to: (1) estimate the disease burden of herpes zoster (HZ) and (2) assess the potential public health impact of introducing adjuvanted recombinant zoster vaccine (RZV) compared with no vaccination in adults aged ≥50 years in Argentina, Brazil, Mexico, Chile, and Colombia using the ZO...
Main Authors: | Ru Han, Jorge A. Gomez, Bruna de Veras, Thatiana Pinto, Adriana Guzman-Holst, Javier Nieto, Désirée A. M. van Oorschot |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-01-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2022.2164144 |
Similar Items
-
Herpes-zóster e neuralgia pós-herpética
by: Ana Virgínia Tomaz Portella, et al. -
Zoster and its lurking shadow
by: Hina Handa, et al.
Published: (2016-01-01) -
Case Report of Herpes Zoster in the 17-year-old Boy
by: Lawrence Tong Kin Nguong, et al.
Published: (2022-06-01) -
Increasing incidence associated with herpes zoster infection in British Columbia, Canada
by: Fawziah Marra, et al.
Published: (2016-10-01) -
Neuralgia pós-herpética em área anatômica pouco usual: relato de caso
by: Ana Virgínia Tomaz Portella, et al.